Barclays analyst Adam Seiden lowered the firm’s price target on Blue Bird (BLBD) to $50 from $54 and keeps an Overweight rating on the shares post the fiscal Q2 report. Blue Bird narrowed but reaffirmed the midpoint of its fiscal 2025 EBITDA range and Q3 is on pace to be another record quarter, the analyst tells investors in a research note. The firm says resiliency in on-highway markets is increasingly harder to find and Blue Bird “still relatively has it.”
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BLBD:
